O’Melveny Worldwide

Yahoo Finance: Biolog-id and Genesis Growth Tech Acquisition Corp. Announce Execution of Business Combination Agreement for Proposed Merger to Create Publicly Listed Digital Health Solutions Company Focused on Value Chain Optimization

September 8, 2022


Medical device firm Biolog-id and special-purpose acquisition company Genesis Growth Tech Acquisition Corp. announced that they have executed the business combination agreement in relation to their proposed merger. The merger is expected to close in the first quarter of 2023 and is still subject to shareholder approval and other closing conditions. O’Melveny & Myers LLP serves as legal counsel to Genesis Growth.

Read the full article here.